Recursion announces collaboration and $50 million investment from NVIDIA

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Recursion recently announced the collaboration and $50 million investment from NVIDIA, bringing together the expertise of both companies. The company also announced plans to accelerate development of its AI foundation models for biology and chemistry, which, in collaboration with NVIDIA, it intends to optimize and distribute to biotechnology companies using NVIDIA cloud services.

Arsheen Kaur
Previous

Epineuron announces launch of FDA clinical trial for bioelectronic therapy for nerve regeneration
Next

Ditch Labs secures $3.25 million to treat nicotine addiction with tech